Clinical, morphological, and molecular genetic predictors of metastatic lesions in the regional lymph nodes in breast cancer-Reference-Cited by-同舟云学术

Clinical, morphological, and molecular genetic predictors of metastatic lesions in the regional lymph nodes in breast cancer

Published:2018-11-10 Issue:3 Volume:5 Page:8-16
ISSN:2413-3787
Container-title:Advances in molecular oncology
language:
Short-container-title:Usp. mol. onkol

Author:

Dergunova Yu. A.¹^ORCID,Podionov V. V.²^ORCID,Bozhenko V. K.³^ORCID,Kometova V. V.⁴^ORCID,Dardyk M. V.⁴^ORCID

Affiliation:

1. Institute of Medicine, Ecology, and Physical Culture, Ulyanovsk State University

2. Institute of Medicine, Ecology, and Physical Culture, Ulyanovsk State University;

3. V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia; Russian Scientific Center of Roentgen Radiology, Ministry of Health of Russia

4. V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Abstract

Despite the sufficient amount of data accumulated in the literature, there are still no factors, on the basis of which it would be possible to estimate the regional lymph nodes status in breast cancer with a high degree of accuracy. The review presents literature data relating to the influence of clinicopathological, molecular-biological and genetic characteristics of primary tumor on lymph node metastases. Data of 66 foreign and Russian articles are included.

Publisher

Publishing House ABV Press

Subject

Cancer Research,Biochemistry, medical,Genetics(clinical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference66 articles.

1. Malignant tumors in Russia in 2015 (morbidity and mortality). Eds.: А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMIRTS” Minzdrava Rossii, 2017. 250 p. (In Russ.).

2. Petrek J.A., Senie R.T., Peters M., Rosen P.P. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001;92(6):1368–77. PMID: 11745212.

3. Silberman A.W., McVay C., Cohen J.S. et al. Comparative morbidity of axillary lymph node dissectionand the sentinel lymph node technique: Implications for patients with breast cancer. Ann Surg 2004;240(1):1–6. PMID: 15213610.

4. Wilke L.G., McCall L.M., Posther K.E. et al. Surgical complications associated with sentinellymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13(4):491–500. DOI: 10.1245/ASO.2006.05.013. PMID: 16514477.

5. Mansel R.E., Fallowfield L., Kissin M. et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operablebreast cancer: The ALMANAC Trial. J Natl Cancer Inst 2006;98(9):599–609. DOI: 10.1093/jnci/djj158. PMID: 16670385.